Sound waves zapping skin cancer? new trial tests HIFU for basal cell carcinoma
NCT ID NCT05133427
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests a new device that uses high-intensity focused ultrasound (HIFU) to treat basal cell carcinoma, the most common skin cancer. Forty adults with either new or recurring skin cancers will receive a single 3-5 minute treatment. Researchers will check if the cancer is gone after 3 months and monitor side effects for one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- High-intensity focused ultrasound (HIFU) device
- What this could lead to
- If successful, this could offer a quick, non-invasive treatment for common skin cancers without surgery.
- What could go wrong
- This is a small early-stage trial with only 40 people. The treatment may not fully remove the cancer or could cause side effects like scarring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, BASAL CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bispebjerg Hospital
Copenhagen, Capital Region, 2400, Denmark
-
Roskilde Hospital
Roskilde, Region Sjælland, 4000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.